8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2019 / Two-year follow-up of an open-label clinical trial
Researchers conducted a two-year follow-up of 18 participants with Autism Spectrum Disorders who previously completed an open-label trial of Microbiota Transfer Therapy (MTT) combining antibiotics, bowel cleanse, acid suppressant, and fecal microbiota transplant. Most improvements in gastrointestinal symptoms were maintained, and autism-related symptoms improved further two years after treatment ended. Important gut microbiota changes persisted, including significant increases in bacterial diversity and relative abundances of Bifidobacteria and Prevotella.
Kang DW, Adams JB, Coleman DM, et al. Sci Rep, 2019. PMID 30967657
2019 / Single-group trial / case series
A lacto-ovo-semivegetarian regimen was integrated into induction therapy for 92 patients hospitalized with ulcerative colitis. Cumulative relapse rates were 14% at 1 year and 27% at 5 years for initial episode cases, and 36% at 1 year and 53% at 5 years for relapse cases. At a mean follow-up of 6 years and 4 months, adherence measured by the plant-based diet score remained significantly higher than baseline (p < 0.0001).
Chiba M, Nakane K, Tsuji T, et al. Perm J, 2019. PMID 31050638
2019 / Prospective endoscopic challenge study
A prospective study challenged 155 patients with IBS using 4 common food components via endoscope followed by confocal laser endomicroscopy (CLE), alongside duodenal biopsy and fluid analysis. Of the 108 patients who completed the study, 76 (70%) had a response to food (CLE+), with 61% of these reacting to wheat. CLE+ patients had significantly higher intraepithelial lymphocytes (P = .001), up-regulated claudin-2 (P = .023), lower occludin levels (P = .022), increased eosinophil degranulation, and higher eosinophilic cationic protein in duodenal fluid (P = .03) compared to controls. Inflammatory cytokine messenger RNA levels remained unchanged after challenge.
Fritscher-Ravens A, Pflaum T, Mösinger M, et al. Gastroenterology, 2019. PMID 31100380
2019 / Pilot study
A pilot study evaluated the postprandial effects of high-fat/high-glycemic load meals enriched with blueberries in 5 obese/overweight patients with metabolic syndrome. Significant decreases in urinary methylamines, acetoacetate, acetone, and succinate were observed at 2 and 4 hours post-ingestion, alongside accumulation of gut-derived phenolic acids. In mononuclear blood cells, mRNA expression of interleukin-6 significantly decreased and transforming growth factor-β significantly increased following blueberry supplementation.
Sobolev AP, Ciampa A, Ingallina C, et al. Metabolites, 2019. PMID 31295937
2019 / Prospective intervention study with a matched control group
Researchers compared 27 overweight/obese women with PCOS to 25 matched controls after a 3-day standardized diet, followed by a 3-month oral contraceptive (OC) intervention with dietary advice in the PCOS group. At baseline, the PCOS group showed significantly higher serum levels of TMAO, choline, betaine, and carnitine, with TMAO and choline correlating with total testosterone. Following the 3-month OC therapy and lifestyle intervention, TMAO and its precursors significantly decreased alongside reductions in BMI, total testosterone, and free androgen index.
Eyupoglu ND, Caliskan Guzelce E, Acikgoz A, et al. Clin Endocrinol (Oxf), 2019. PMID 31556132
2018 / Crossover trial
Eight non-heat-acclimated humans ran for 60 minutes in hot conditions after 3 days of 500 mg/day curcumin or placebo. Intestinal fatty acid-binding protein increased less with curcumin (18% to 58%) than placebo (33% to 87%). Placebo triggered significant rises in TNF-α and IL-10 (P < 0.01), whereas curcumin prevented significant changes. Curcumin also lowered the physiological strain index between 40 and 60 minutes of exercise (P < 0.01).
Szymanski MC, Gillum TL, Gould LM, et al. J Appl Physiol (1985), 2018. PMID 28935827
2018 / Randomized crossover trial
In a crossover trial, 14 healthy volunteers in Mali tested gastric emptying rates of eight starchy staples using a carbon-13 octanoic acid breath test, followed by a 6-volunteer validation study. Traditional sorghum and millet foods showed gastric half-emptying times approximately twice as long as white rice, potato, or pasta (p < 0.0001). Pre-test assessments ranked millet couscous and rice as more filling, aligning with postprandial hunger ratings.
Cisse F, Erickson DP, Hayes AMR, et al. Nutrients, 2018. PMID 29373493
2018 / Double-blind, randomized, placebo-controlled trial
A double-blind, randomized, placebo-controlled trial evaluated the efficacy of Amla (Phyllanthus emblica L.) tablets in 68 patients with non-erosive reflux disease. Participants took two 500 mg Amla tablets or placebo twice daily after meals for 4 weeks. Heartburn and regurgitation frequencies significantly dropped in both groups (P < 0.001), but repeated measures logistic regression demonstrated a significantly greater reduction in the frequency and severity of both heartburn and regurgitation in the Amla group compared to placebo (P < 0.001).
Karkon Varnosfaderani S, Hashem-Dabaghian F, Amin G, et al. J Integr Med, 2018. PMID 29526236
2018 / Randomized controlled trial
Twenty men with metabolic syndrome received either autologous or lean vegan-donor fecal transplants. After two weeks, vegan-donor transplants altered microbial community structure toward a vegan profile in some participants. However, the intervention caused no functional changes in TMAO synthesis from choline or carnitine, aortic radiotracer uptake, or cytokine generation from isolated immune cells.
Smits LP, Kootte RS, Levin E, et al. J Am Heart Assoc, 2018. PMID 29581220
2018 / Randomized clinical study
A randomized clinical study of specifically designed isoenergetic diets paired with fecal shotgun metagenomics evaluated the effect of dietary fibers in patients with type 2 diabetes mellitus. Dietary fibers selectively promoted a specific group of short-chain fatty acid (SCFA)-producing strains while diminishing or leaving unchanged most other potential producers. Greater diversity and abundance of these fiber-promoted SCFA producers led to greater improvements in hemoglobin A1c levels, partly through increased glucagon-like peptide-1 production, and diminished bacteria producing detrimental compounds like indole and hydrogen sulfide.
Zhao L, Zhang F, Ding X, et al. Science, 2018. PMID 29590046
2018 / Clinical trial
A trial compared the effect of Psyllium seed and oral omeprazole on GERD in 132 patients with functional constipation split into two groups. The treatment response rate was 89.2% (n = 58) in the Psyllium seed group compared to 94% (n = 63) in the omeprazole group (P = .31). However, the recurrence rate was significantly lower with Psyllium seed at 24.1% (n = 14) compared to 69.8% (n = 44) with omeprazole (P < .001).
Hosseini M, Salari R, Akbari Rad M, et al. J Evid Based Integr Med, 2018. PMID 29607676
2018 / Single-blinded randomized controlled trial
In a single-blinded randomized controlled trial, 53 constipated patients with type 2 diabetes received either 10 g of flaxseed pre-mixed in cookies twice daily or placebo cookies for 12 weeks. Compared with placebo, the flaxseed group showed statistically significant improvements in absolute change for constipation symptom scores (2.46 vs. 0.41), weight (-3.8 vs. 0.0 kg), BMI (-1.5 vs. -0.1 kg/m2), FPG (-26.7 vs. -1.9 mg/dl), HbA1c (-0.8 vs. 1.0%), cholesterol (-37.3 vs. -10.4 mg/dl), LDLC (-21.0 vs. -4.3 mg/dl), and HDLC (4.7 vs. -4.4 mg/dl; all P < 0.05). Compliance was reported as good, and no adverse effects were observed.
Soltanian N, Janghorbani M Nutr Metab (Lond), 2018. PMID 29760761
2018 / Interventional study with within-subject meal comparison
Researchers evaluated 165 endoscopy-negative heartburn patients undergoing 24-hour impedance-pH monitoring while consuming a Mediterranean diet split into two balanced meals: one predominantly animal protein and one vegetable protein. In the first postprandial hour, the animal protein meal resulted in a higher total reflux number, acid reflux number, acid exposure time (AET), and more reported symptoms compared to the vegetable protein meal. Similar findings were seen across subgroups of nonerosive reflux disease (55/165), hypersensitive esophagus (49/165), and functional heartburn (61/165). The authors noted this was a pilot study requiring future confirmation.
Martinucci I, Guidi G, Savarino EV, et al. Gastroenterol Res Pract, 2018. PMID 29849599
2018 / Crossover study (in human volunteers)
Researchers tested whether an antioxidant marinade on beef with various degrees of cooking could limit lipid peroxidation and carcinogenesis in rats, Min mice, and human volunteers in a crossover study. Fresh beef increased lipoperoxidation in humans, rats, and mice, and increased colon carcinogenesis in the rodents. Without adverse organoleptic effects, the marinade reduced peroxidation biomarkers in human feces, normalized them in rodent feces, and reduced mucin-depleted foci in rats and adenomas in female Min mice.
Martin OCB, Naud N, Taché S, et al. Cancer Prev Res (Phila), 2018. PMID 29954759
2018 / Single-group prospective trial
Sixty patients with mild ulcerative colitis or UC in remission received a plant-based diet (PBD) and dietary guidance during a two-week educational hospitalization. Over a median follow-up of 3 years 6 months, 8 cases relapsed, with cumulative relapse rates at 1, 2, 3, 4, and 5 years of 2%, 4%, 7%, 19%, and 19%, respectively. During hospitalization, 77% of patients experienced improvement such as disappearance or decrease of bloody stool. Both short- and long-term PBD scores remained higher than baseline.
Chiba M, Nakane K, Tsuji T, et al. Perm J, 2018. PMID 30005726
2018 / Prospective single-arm study
Twenty children with refractory epilepsy were prospectively evaluated before and 6 months after starting a ketogenic diet. Following 6 months of therapy, 2 patients became seizure-free, 3 achieved a ≥ 90% reduction, 5 had a 50-89% reduction, and 10 had a < 50% reduction, with all 10 responders showing EEG improvements. Fecal microbial profiles demonstrated lower alpha diversity compared with baseline, along with significantly decreased Firmicutes and increased Bacteroidetes abundance. Non-responsive patients were found to have enrichment of Clostridiales, Ruminococcaceae, Rikenellaceae, Lachnospiraceae, and Alistipes.
Zhang Y, Zhou S, Zhou Y, et al. Epilepsy Res, 2018. PMID 30007242
2018 / Invasive intervention study in humans and mice
Researchers examined the effects of multi-strain probiotics or autologous fecal microbiome transplantation (aFMT) on post-antibiotic reconstitution of the murine and human mucosal microbiome niche. Compared to spontaneous recovery, probiotics caused markedly delayed and persistently incomplete indigenous stool and mucosal microbiome reconstitution and host transcriptome recovery toward homeostasis. Conversely, aFMT promoted a rapid and near-complete recovery within days of administration.
Suez J, Zmora N, Zilberman-Schapira G, et al. Cell, 2018. PMID 30193113
2018 / Dietary intervention study
In a 6-month dietary intervention among 32 individuals with nonalcoholic fatty liver disease, average daily fiber intake rose from 19 g to 29 g. Serum zonulin dropped by nearly 90% (7.335 vs. 0.507 ng/mL, P = 0.001) and was correlated with fiber intake (P = 0.043) and steatosis grade (P = 0.037). Participants also displayed significant improvements in liver enzymes, triglycerides (P = 0.036), HOMA-IR (P = 0.041), and fatty liver score (P = 0.009).
Krawczyk M, Maciejewska D, Ryterska K, et al. Nutrients, 2018. PMID 30453660
2018 / Prospective, non-randomized, 8-week pilot study
Nine adolescents with inflammatory bowel disease participated in an 8-week intervention combining in-person yoga classes with online videos. All nine attended at least two in-person classes, and eight engaged in one or more videos weekly. Participants reported reduced stress, improved emotional self-awareness, and better ability to manage physical symptoms, although time limitations hindered completing the videos. The study lacked statistical power to detect significant changes in disease severity (PUCAI), fecal calprotectin, or PROMIS-37 wellness domains.
Arruda JM, Bogetz AL, Vellanki S, et al. Complement Ther Med, 2018. PMID 30477870
2018 / Non-randomized controlled trial
In a non-randomized controlled trial, young adults underwent gastrointestinal tolerance tests with stepwise dose escalations of D-allulose. No severe diarrhea or gastrointestinal symptoms appeared up to 0.4 g/kg body weight, but severe diarrhea occurred at 0.5 g/kg body weight. Compared to sugar, D-allulose was linked to higher frequencies of diarrhea (p = 0.004), abdominal distention (p = 0.039), and abdominal pain (p = 0.031), while escalating total daily intake to 1.0 g/kg body weight produced severe nausea, headache, anorexia, and diarrhea.
Han Y, Choi BR, Kim SY, et al. Nutrients, 2018. PMID 30572580
2017 / Randomized, double-blind, placebo-controlled trial
Forty-two children aged 7-12 years with BMI >=85th percentile were randomized to receive 8 g/d of oligofructose-enriched inulin or maltodextrin placebo for 16 weeks. Compared with placebo, prebiotics led to significantly higher fullness (P = 0.04) and lower prospective food consumption (P = 0.03) at a week 16 breakfast buffet, and significantly reduced energy intake in 11- to 12-year-olds (P = 0.04) but not 7- to 10-year-olds. Fasting adiponectin (P = 0.04) and ghrelin (P = 0.03) significantly increased with prebiotics compared to placebo. Prebiotic supplementation showed a trend toward reducing BMI z score in intent-to-treat analysis (-3.4%; P = 0.09) and a significant -3.8% reduction in per-protocol analysis (P = 0.043).
Hume MP, Nicolucci AC, Reimer RA Am J Clin Nutr, 2017. PMID 28228425
2017 / Intervention pilot study
A pilot study evaluated the effect of soymilk intake on the fecal microbiota and metabolic activities in eight healthy adult humans. During the intake period, the number of bifidobacteria in feces was significantly higher on day 14 compared to baseline (p<0.05), while Enterobacteriaceae counts were significantly lower on days 7 and 14 (p<0.05). At the species or group level, all Bifidobacterium groups studied slightly increased, suggesting soymilk intake may contribute to improving the intestinal environment.
Fujisawa T, Ohashi Y, Shin R, et al. Biosci Microbiota Food Health, 2017. PMID 28243549
2017 / Randomized controlled trial
Children and adolescents with intractable epilepsy were randomized to a ketogenic diet (KD) or care as usual (CAU) and followed for 16 months. In total, 58% of the KD group completed follow-up (11 dropped out). At 16 months, 35% of KD participants achieved a seizure reduction of ≥50% from baseline versus 18% in the CAU group, and 46.2% reported decreased worst seizure severity versus 32% in CAU. Mean per-patient costs were €61,019 in the KD group compared with €53,367 (extrapolated) in CAU, giving an ICER of €46,564 per responder. The KD group had significantly more gastrointestinal issues at 4 months but fewer at 16 months compared to CAU; cost per QALY ratios were inconclusive due to minimal QALY differences.
Wijnen BFM, de Kinderen RJA, Lambrechts DAJE, et al. Epilepsy Res, 2017. PMID 28364726
2017 / Randomized controlled trial
A randomized controlled trial evaluated 77 patients with ulcerative colitis in clinical remission assigned to 12 weekly 90-minute yoga sessions (n=39) or written self-care advice (n=38). The yoga group had significantly higher disease-specific quality of life at week 12 (Δ = 14.6; 95% CI 2.6 to 26.7; P = 0.018) and week 24 (Δ = 16.4; 95% CI 2.5 to 30.3; P = 0.022). Disease activity was lower in the yoga group at week 24 (Δ = -1.2; 95% CI -0.1 to -2.3; P = 0.029). Serious adverse events occurred in 3 yoga patients and 1 self-care patient (P = 0.317), while non-serious adverse events occurred in 7 and 8 patients, respectively (P = 0.731).
Cramer H, Schäfer M, Schöls M, et al. Aliment Pharmacol Ther, 2017. PMID 28378342